Hao Wang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 14
- Oncology 69
- Pancreatic and Hepatic Oncology Research 24
- Peptidase Inhibition and Analysis 14
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Qingyu Wu (14 shared papers)Louis M. Weiner (2 shared papers)Lijie Tan (26 shared papers)Melvyn Goldberg (1 shared paper)Adam C. Berger (1 shared paper)Walter J. Scott (1 shared paper)Jeffrey M. Farma (1 shared paper)Jonathan D. Cheng (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Advanced Functional Materials (9 papers)Advanced Science (8 papers)Frontiers in Immunology (8 papers)Journal of the American Chemical Society (8 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hao Wang
366 papers receiving 6.8k citations
Peers
Comparison fields: 5 of 178
- Cancer Research 681
- Oncology 1.2k
- Molecular Biology 2.0k
- Surgery 1.2k
- Pulmonary and Respiratory Medicine 826
Countries citing papers authored by Hao Wang
This map shows the geographic impact of Hao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Wang more than expected).
Fields of papers citing papers by Hao Wang
This network shows the impact of papers produced by Hao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Wang. The network helps show where Hao Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 593 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 415 | |
| 2 | 2019 | 196 | |
| 3 | 2015 | 144 | |
| 4 | 2003 | 135 | |
| 5 | 2015 | 104 | |
| 6 | 2018 | 102 | |
| 7 | 2010 | 96 | |
| 8 | 2021 | 92 | |
| 9 | 2005 | 88 | |
| 10 | 2020 | 87 | |
| 11 | 2019 | 85 | |
| 12 | 2013 | 77 | |
| 13 | 2018 | 71 | |
| 14 | 2022 | 70 | |
| 15 | 2013 | 70 | |
| 16 | 2021 | 70 | |
| 17 | 2007 | 66 | |
| 18 | 2015 | 66 | |
| 19 | 2016 | 66 | |
| 20 | 2009 | 66 |
About Hao Wang
Hao Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 593 papers that have together received 6.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (24 papers), Esophageal Cancer Research and Treatment (23 papers), Cancer Genomics and Diagnostics (15 papers), RNA modifications and cancer (14 papers), Peptidase Inhibition and Analysis (14 papers), Ferroptosis and cancer prognosis (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and MicroRNA in disease regulation (10 papers). The work is most often cited by research in Cancer Research (681 citations), Oncology (1.2k citations), Molecular Biology (2.0k citations), Surgery (1.2k citations) and Pulmonary and Respiratory Medicine (826 citations). Hao Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qingyu Wu, Louis M. Weiner, Lijie Tan, Melvyn Goldberg, Adam C. Berger, Walter J. Scott, Jeffrey M. Farma, Jonathan D. Cheng, Gary M. Freedman and Wei Song. Their work appears in journals such as Journal of Clinical Oncology, Advanced Functional Materials, Advanced Science, Frontiers in Immunology and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.